查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2046205

獸用立體定位放射外科系統市場－全球產業規模、佔有率、趨勢、機會、預測：依產品、應用、最終用戶、地區、競爭格局分類，2021-2031年

Veterinary Stereotactic Radiosurgery System Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球獸用SRS系統市場預計將從2025年的36.6億美元成長到2031年的66.3億美元，複合年成長率為10.41%。

獸用立體定位放射手術（SRS）系統是一種專門用於治療伴侶動物腫瘤的醫療設備，它透過精準地將高劑量輻射輸送到患處，同時小心地保護周圍健康組織。這一市場擴張的主要驅動力是老年寵物癌症發病率的上升以及寵物「人性化」趨勢的日益成長，這反過來又促使飼主投資於先進的獸醫護理。此外，獸醫腫瘤學的快速發展以及專業轉診機構的日益普及也顯著促進了這些系統的採用。美國寵物產品協會的數據顯示，到2024年，美國獸醫支出和產品銷售額將達到398億美元，這印證了上述趨勢。

市場概覽
預測期 2027-2031
市場規模：2025年 36.6億美元
市場規模：2031年 66.3億美元
複合年成長率：2026-2031年 10.41%
成長最快的細分市場 腦腫瘤
最大的市場 北美洲

市場促進因素

獸醫患者癌症和腫瘤發生率的不斷上升是推動全球獸醫立體定位放射手術（SRS）系統市場發展的主要動力。隨著伴侶動物壽命的延長，罹患腦瘤、骨癌和鼻腔癌等腫瘤性疾病的風險也隨之增加，因此對精準且非侵入性治療方法的需求日益成長。 SRS作為一種重要的替代侵入性手術的方法，正獲得越來越多的支持，因為它能夠在保護健康組織的同時，將可切除劑量的放射線精準地輸送到這些複雜的靶區。美國獸醫協會（AVMA）強調了這些疾病的高發生率，該協會在2025年2月發布的報告顯示，大約四分之一的犬隻在其一生中會患有癌症，這直接推動了對先進腫瘤治療的需求。同時，寵物「人性化」的趨勢以及不斷上漲的醫療保健成本，正在消除採用這些先進系統的經濟障礙。寵物飼主越來越將他們的犬隻視為家庭成員，因此也更願意投資高品質的醫療保健。寵物保險產業的蓬勃發展進一步推動了這一趨勢。北美寵物健康保險協會的數據也印證了這個財務空間，該協會預測，到2024年，美國寵物保險總保費將達到47億美元，比前一年成長21.4%。投保寵物數量的激增以及由此帶來的經濟負擔加重，正在推動專業醫療基礎設施的發展。例如，正如《今日獸醫實踐》2025年6月刊所指出的，到2024年，北美地區獲得委員會認證的獸醫腫瘤學家數量將達到600人，這將有助於放射外科手術平台的更廣泛應用。

市場挑戰

引進和安裝獸用立體定位放射外科（SRS）系統所需的巨額資本投入是全球市場擴張的一大障礙。這筆經濟負擔不僅包括初始購買成本，還包括建造專用輻射屏蔽室、維修現有基礎設施以及持續營運成本，例如維護費用和獸醫腫瘤學家、醫學物理學家等高素質專業人員的人事費用。因此，這一經濟壁壘使得SRS技術的應用主要局限於資金雄厚的專科醫院和學術機構，實際上將絕大多數私立獸醫診所排除在外，使其無法採用這些先進系統。美國獸醫學會（AVMA）發布的《2025年獸醫經濟狀況報告》顯示，2024年美國獸醫診所的平均總收入約為150萬美元，由此可見度數。由於SRS系統的價格通常遠遠超過診所的年收入，大多數獸醫診所根本無法負擔引進這項技術的費用。由於難以使其價格合理，因此大大限制了潛在的市場規模，並阻礙了 SRS 功能在醫療產業的廣泛應用。

市場趨勢

獸醫腫瘤學領域正經歷著一場根本性的變革，其驅動力在於低分割立體定位放射治療方案的日益普及。這些方案以高度精確、緊湊的治療計劃取代了漫長的數週放射治療療程，從而重新定義了臨床標準。這項轉變的主要動機在於，伴侶動物麻醉相關風險亟需最小化，因為低分割治療只需一到三次療程即可達到可切除的劑量，而傳統的治療方案則需要更長時間。這些先進治療方法的快速普及在近期的臨床病例數量中得到了清楚的體現。美國國立衛生研究院 (NIH) 於 2025 年 11 月發表的一項關於獸醫放射治療趨勢的回顧性研究顯示，四年內接受放射治療的患者數量顯著成長了 103.4%，凸顯了臨床對這些先進高效治療方案日益成長的需求。同時，立體定位放射治療（SRS）技術在私立專科轉診中心的普及，正在使先進的癌症治療分散化，使其不再局限於學術教學醫院，而是擴展到更廣泛的企業化獸醫醫療保健網路。大規模私立醫療集團正透過大力投資最先進的線性加速器和招募認證人員，建立起堪比大學的、以研究主導的新型私立醫療保健體系。這種結構性演進可以透過這些私立機構的學術產出來量化。根據瑪氏寵物健康公司於2025年4月發布的首份“科學影響報告”，其全球網路中的臨床醫生在一年內發表了超過450篇同行評審論文。這表明，私人轉診中心正成為臨床創新和擴大放射外科服務覆蓋範圍的關鍵驅動力。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球獸用SRS系統市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 產品細分（伽瑪刀、直線加速器、質子束治療（PBRT）/閃光放射治療、電腦刀）
    • 按應用（腦瘤、脊髓瘤、其他）
    • 依最終使用者（獸醫院、專科獸醫診所、研究和學術機構）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美獸用SRS系統市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲獸用SRS系統市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區獸用SRS系統市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東與非洲獸用SRS系統市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美獸用SRS系統市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球獸用SRS系統市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Avante Health Solutions LLC
  • Accuray Inc.
  • Elekta AB
  • Varian Medical Systems Inc.
  • PetCure Oncology LLC
  • Xstrahl Inc.
  • CVS Group
  • Medtronic PLC
  • Nanovi AS
  • Merck & Co. Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球獸用SRS系統市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 產品細分（伽瑪刀、直線加速器、質子束治療（PBRT）/閃光放射治療、電腦刀）
    • 按應用（腦瘤、脊髓瘤、其他）
    • 依最終使用者（獸醫院、專科獸醫診所、研究和學術機構）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美獸用SRS系統市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲獸用SRS系統市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區獸用SRS系統市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東與非洲獸用SRS系統市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美獸用SRS系統市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球獸用SRS系統市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Avante Health Solutions LLC
  • Accuray Inc.
  • Elekta AB
  • Varian Medical Systems Inc.
  • PetCure Oncology LLC
  • Xstrahl Inc.
  • CVS Group
  • Medtronic PLC
  • Nanovi AS
  • Merck & Co. Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 28300

The Global Veterinary Stereotactic Radiosurgery (SRS) System Market is projected to grow from USD 3.66 billion in 2025 to USD 6.63 billion by 2031, demonstrating a compound annual growth rate of 10.41%. Veterinary SRS systems are specialized medical devices that deliver high-dose, precisely targeted radiation to treat neoplastic tumors in companion animals while meticulously preserving surrounding healthy tissue. This market's expansion is primarily fueled by the increasing prevalence of cancer within the aging pet population and the growing trend of pet humanization, which drives owners' willingness to invest in advanced veterinary care. Furthermore, rapid advancements in veterinary oncology and the increasing availability of specialized referral centers contribute significantly to the adoption of these systems. As evidence of this commitment, expenditures on veterinary care and product sales in the United States alone reached $39.8 billion in 2024, according to the American Pet Products Association.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 3.66 Billion
Market Size 2031USD 6.63 Billion
CAGR 2026-203110.41%
Fastest Growing SegmentBrain Tumours
Largest MarketNorth America

Market Driver

The escalating incidence of cancer and tumors in veterinary patients is a primary force propelling the Global Veterinary Stereotactic Radiosurgery System Market. As companion animals live longer, they become more susceptible to neoplastic conditions such as brain tumors, osteosarcoma, and nasal carcinomas, necessitating precise, non-invasive treatment alternatives. Stereotactic radiosurgery is increasingly preferred for its capacity to deliver ablative radiation doses to these complex targets while preserving healthy tissue, providing a crucial alternative to invasive surgeries. The significant prevalence of such diseases is highlighted by the American Veterinary Medical Association, which reported in February 2025 that approximately one in four dogs will develop cancer during their lifetime, directly fueling the demand for advanced oncology interventions. Simultaneously, the rising trend of pet humanization, coupled with increased healthcare expenditure, is dismantling financial barriers to adopting these sophisticated systems. Pet owners are increasingly treating their animals as integral family members, which translates into a greater willingness to invest in premium medical care, a sentiment further bolstered by the expanding pet insurance sector. This financial capacity is quantitatively supported by data from the North American Pet Health Insurance Association, indicating that the total premium volume in the United States reached $4.7 billion in 2024, marking a 21.4% increase from the previous year. This surge in insured pets and the corresponding financial commitment facilitate the infrastructure for specialized care, exemplified by the growth to 600 board-certified veterinary oncologists in North America by 2024, as noted by Today's Veterinary Practice in June 2025, thereby supporting the wider deployment of radiosurgery platforms.

Market Challenge

The substantial capital expenditure required for acquiring and installing Veterinary Stereotactic Radiosurgery (SRS) systems presents a significant impediment to the global market's expansion. This financial burden extends beyond the initial purchase price, encompassing the costs of constructing specialized radiation-shielded vaults, retrofitting existing infrastructure, and covering ongoing operational expenses such as maintenance and salaries for highly specialized personnel like veterinary oncologists and medical physicists. Consequently, this economic barrier primarily restricts the accessibility of SRS technology to affluent specialty hospitals and academic institutions, effectively excluding the vast majority of private veterinary practices from adopting these advanced systems. The disparity is evident when considering that, according to the American Veterinary Medical Association's 2025 Report on the Economic State of the Veterinary Profession, the average gross revenue for a U.S. veterinary practice was approximately $1.5 million in 2024. Given that SRS systems often cost substantially more than typical annual earnings, most veterinary facilities lack the financial capacity to implement such technology. This lack of affordability severely limits the total addressable market and prevents the widespread proliferation of SRS capabilities across the broader veterinary sector.

Market Trends

The veterinary oncology landscape is undergoing a fundamental transformation driven by the increasing adoption of hypofractionated stereotactic treatment protocols, which are redefining clinical standards by replacing prolonged, multi-week radiation courses with high-precision, condensed regimens. This shift is primarily motivated by the critical need to minimize anesthesia-related risks in companion animals, as hypofractionation delivers ablative doses in as few as one to three sessions, contrasting sharply with traditional protracted protocols. The rapid integration of these advanced modalities is clearly reflected in recent clinical caseloads; a retrospective study on veterinary radiation trends, published by the National Institutes of Health in November 2025, reported a remarkable 103.4% increase in the number of patients receiving radiation therapy over a four-year period, underscoring the escalating clinical demand for these sophisticated and efficiency-enhancing treatment options. Concurrently, the proliferation of SRS capabilities in private specialty referral centers is decentralizing advanced cancer care, moving it beyond the exclusive domain of academic teaching hospitals into broader corporate veterinary networks. Large private health groups are making significant investments in state-of-the-art linear accelerators and recruiting board-certified talent, thereby establishing a new echelon of research-driven private practice that rivals the capabilities of university institutions. This structural evolution is quantitatively demonstrated by the academic productivity of these private entities; Mars Veterinary Health's inaugural Science Impact Report in April 2025 revealed that clinicians within its global network authored over 450 peer-reviewed manuscripts in a single year, illustrating how private referral centers have become pivotal drivers of clinical innovation and are expanding the accessibility of radiosurgery services.

Key Market Players

  • Avante Health Solutions LLC
  • Accuray Inc.
  • Elekta AB
  • Varian Medical Systems Inc.
  • PetCure Oncology LLC
  • Xstrahl Inc.
  • CVS Group
  • Medtronic PLC
  • Nanovi AS
  • Merck & Co. Inc.

Report Scope

In this report, the Global Veterinary Stereotactic Radiosurgery System Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Stereotactic Radiosurgery System Market, By Product

  • Gamma Knife
  • LINAC
  • Proton Beam Radiation Therapy (PBRT)/ Flash-RT
  • CyberKnife

Veterinary Stereotactic Radiosurgery System Market, By Application

  • Brain Tumours
  • Spinal Tumours
  • Other Applications

Veterinary Stereotactic Radiosurgery System Market, By End User

  • Veterinary Hospitals
  • Veterinary Specialty Clinics
  • Research & Academic Institutions

Veterinary Stereotactic Radiosurgery System Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Stereotactic Radiosurgery System Market.

Available Customizations:

Global Veterinary Stereotactic Radiosurgery System Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Veterinary Stereotactic Radiosurgery System Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Gamma Knife, LINAC, Proton Beam Radiation Therapy (PBRT)/ Flash-RT, CyberKnife)
    • 5.2.2. By Application (Brain Tumours, Spinal Tumours, Other Applications)
    • 5.2.3. By End User (Veterinary Hospitals, Veterinary Specialty Clinics, Research & Academic Institutions)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Veterinary Stereotactic Radiosurgery System Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Veterinary Stereotactic Radiosurgery System Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Veterinary Stereotactic Radiosurgery System Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Veterinary Stereotactic Radiosurgery System Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Veterinary Stereotactic Radiosurgery System Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Veterinary Stereotactic Radiosurgery System Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. France Veterinary Stereotactic Radiosurgery System Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Veterinary Stereotactic Radiosurgery System Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Veterinary Stereotactic Radiosurgery System Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Veterinary Stereotactic Radiosurgery System Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia Pacific Veterinary Stereotactic Radiosurgery System Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Veterinary Stereotactic Radiosurgery System Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Veterinary Stereotactic Radiosurgery System Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Veterinary Stereotactic Radiosurgery System Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Veterinary Stereotactic Radiosurgery System Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Veterinary Stereotactic Radiosurgery System Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. Middle East & Africa Veterinary Stereotactic Radiosurgery System Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Veterinary Stereotactic Radiosurgery System Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Veterinary Stereotactic Radiosurgery System Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Veterinary Stereotactic Radiosurgery System Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. South America Veterinary Stereotactic Radiosurgery System Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Veterinary Stereotactic Radiosurgery System Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Veterinary Stereotactic Radiosurgery System Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Veterinary Stereotactic Radiosurgery System Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Veterinary Stereotactic Radiosurgery System Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Avante Health Solutions LLC
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Accuray Inc.
  • 15.3. Elekta AB
  • 15.4. Varian Medical Systems Inc.
  • 15.5. PetCure Oncology LLC
  • 15.6. Xstrahl Inc.
  • 15.7. CVS Group
  • 15.8. Medtronic PLC
  • 15.9. Nanovi AS
  • 15.10. Merck & Co. Inc.

16. Strategic Recommendations

17. About Us & Disclaimer